Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nutramax Laboratories Inc.

www.nutramaxlabs.com

Latest From Nutramax Laboratories Inc.

Industry Roundup: Carlyle Backs Pharma Venture, Nutranomics CEO Returns

NSF adds 'next generation' DNA ID service; Dietary Guidelines updated; NPA in anti-internet tax coalition; GNC hires financial communications firm; and more news in brief.

Dietary Supplements Wellness

Study Makes MOVES For Chondroitin/Glucosamine On Osteoarthritis Pain

At six months, 79.7% of the moderate-to-severe patients in the supplementation group and 79.2% in the celecoxib group fulfilled pain reduction criteria, the primary outcome measured in the Multicenter Osteoarthritis InterVEntion trial with SYSADOA.

Consumer Germany

Study Makes MOVES For Chondroitin/Glucosamine On Osteoarthritis Pain

At six months, 79.7% of the moderate-to-severe patients in the supplementation group and 79.2% in the celecoxib group fulfilled pain reduction criteria, the primary outcome measured in the Multicenter Osteoarthritis InterVEntion trial with SYSADOA.

Consumer Germany

Efficacy Evidence Opens Door To Sell More Doctors On Joint Health Supplements

Some doctors need more than impressive study results to change their routines, says Nicholas DiNubile, an orthopedic surgeon and a proponent of chondroitin/glucosamine supplementation for osteoarthritis patients. The patients, he says, often are asking about options to treatment with NSAIDs.

Consumer BioPharmaceutical
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register